4 studies found for:    ald403
Show Display Options
Rank Status Study
1 Completed Safety Tolerability and Pharmacokinetics of ALD403
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Sumatriptan
2 Completed Safety, Efficacy and Pharmacokinetics of ALD403
Condition: Migraine
Intervention: Biological: ALD403
3 Completed Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Condition: Hepatitis C Virus
Interventions: Drug: Asunaprevir (ASV);   Drug: Daclatasvir (DCV);   Drug: Pegylated-interferon alfa 2a (PegIFN);   Drug: Ribavirin (RBV)
4 Completed Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
Condition: Hepatitis C Virus
Interventions: Drug: Asunaprevir;   Drug: Daclatasvir;   Drug: Peg-interferon Alfa-2a;   Drug: Ribavirin

Indicates status has not been verified in more than two years